FDA Office Of Pharmacoepidemiology Units Slated For September Move
Executive Summary
Divisions from FDA's Office of Pharmacoepidemiology & Statistical Science (OPaSS) are expected to relocate to the agency's new White Oak, Md. campus in mid-September
You may also be interested in...
CDER's Generational Shift: Many New Reviewers With Little Experience
The last two fiscal years have seen great gains in the number of new employees hired in FDA's Center for Drug Evaluation & Research, but the result is a relatively under-experienced staff: 38 percent of employees in both CDER and the Office of New Drugs have less than two years of on-the-job experience
CDER's Generational Shift: Many New Reviewers With Little Experience
The last two fiscal years have seen great gains in the number of new employees hired in FDA's Center for Drug Evaluation & Research, but the result is a relatively under-experienced staff: 38 percent of employees in both CDER and the Office of New Drugs have less than two years of on-the-job experience
FDA Phasing In Restructuring Of Drug Office; Move To White Oak Postponed
FDA is proceeding with the restructuring of the Office of New Drugs ahead of a formal switch to the new organization in September